... , but increasing numbers of men with earlier stages of the disease are also undergoing the treatment.
Prostate cancer patients who are prescribed these drugs often stay on them for the duration of ...
... radiation therapy for overweight or obese prostate cancer patients, according to a study published in the August issue ... treatment for obese men with early-stage prostate cancer," Anthony Zietman, M.D ...
... known to scientists. When they looked for these sequences in cells isolated from 124 prostate cancer patients, they found over-production of these outlaw variants in prostate cancer cells taken from ...
... on statins versus prostate cancer patients not on statins," says study lead author Piyush K. ... . Gleason 7 disease accounted for the majority of cancers in the study group, with 57 in the statin group ...
... long-term survival for younger prostate cancer patients, Pokala and Menon studied more than 8, ... moderately and 22 percent had poorly differentiated cancers. Of the patients, 1,065 were managed with no ...
... New York followed 742 prostate cancer patients who were treated with brachytherapy alone, brachytherapy ... would do in the future and the overall chance of being cancer free at 10 years was 97 percent. ...
... eight years after their initial diagnosis, and compared it with data provided by prostate-cancer patients who had opted for aggressive treatment, such as surgery, radiotherapy or hormonal therapy.
" ...
... recurrence or biochemical failure rates in prostate cancer patients receiving EBRT. Researchers at the Carol ... percent compared to only 1.3 percent for patients of a normal weight.
IGRT is a new type ...
Appropriately selected prostate cancer patients, including older men and men with small, low-risk tumors, may safely defer treatment for many years with no adverse ...
... treatment choices, but 38% got a combination of the two types of drugs.
"We found that prostate cancer patients treated with hormone therapy had an elevated risk of developing all of the individual ...
... method for locating the prostatic apex for radiation therapy treatment planning in prostate cancer patients because it eliminates the need for an invasive procedure and the related side effects, ...
... panel of seven biomarkers that can predict with 86 percent accuracy which prostate cancer patients will experience a recurrence and progression of the disease. Biomarkers are proteins circulating in ...
... agreement Tuesday to collaborate with the German biopharmaceutical company CureVac to test an experimental therapy for advanced prostate cancer patients who no longer respond to traditional treatment.
... this information to decide whether to take a "watchful waiting" approach with their prostate cancer patients or to move to more aggressive additional therapy such as hormone therapy, chemotherapy or ...
... the findings have important implications for guiding treatment decisions for prostate cancer patients.
"Vaccines, if and when they are approved, can be safely and effectively combined with other ...
